Following the split of Baxter International’s global business, the company has renamed the biopharmaceuticals business, Baxalta, Inc. The corporate headquarters for both companies will be located in northern IL. Robert L. Parkinson, Jr., is serving as chairman and chief executive officer of the medical products company, which will retain the Baxter International name, and Ludwig N. Hantson, Ph.D., president of Baxter BioScience, is now chief executive officer of Baxalta.    ”The naming of ...